Available tests:
Karyotyping (when bone marrow is infiltrated);
Fluorescence in situ hybridisation on FFPE tissue sections, FNA's, cytospins:
IGH-MYC to detect t(8;14); MYC (8q24) to detect variant rearrangements;
IGH-CCND1 to detect t(11;14);
IGH-BCL2 to detect t(14;18);
ALK;
BCL6 t(3q27;?);
IGH-MALT1 t(14;18);
API2-MALT1 t(11;18);
Clinical details
A number of cytogenetic abnormalities are specific to certain sub-types of non-Hodgkin's lymhoma (NHL) and as such can be very useful in aiding diagnosis, particularly where histopathology and immunophenotyping is ambiguous. The detection of MYC abnormalities can be especially critical in optimising therapy, where a confirmed diagnosis of Burkitt lymphoma (BL) determines a very disease-specific treatment regimen. MYC abnormalities are also detected in diffuse large B-cell lymhoma (DLBCL) and in B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and BL (intermediate BL/DLBCL), and this has been shown to be an adverse prognsotic risk factor in patients treated with R-CHOP. MYC rearangements can also be detected along with BCL2 and/or BCL6 rearrangements, especially in intermediate BL/DLBCL, identifying the so-called double hit lymphomas which are associated with a particularly aggressive clinical course. Analysis of NHL's lends itself particularly well to interphase FISH analysis of formalin-fixed paraffin-embedded (FFPE) tissue sections, where close corrleation with H&E and/or immunohistochemistry (IHC) slides enables the analysis of small focal tumour infiltrates and removes the risk of false negative results arising from analysis of non-malignant cells.
Peripheral blood, bone marrow aspirate, pleural effusion, fine needle aspirate, as appropriate, minimum volume as available. FFPE tissue sections - 3-4µm sections on unstained Apes slides with appropriate IHC/H&E slide for correlation
Storage and transport
Peripheral blood in lithium heparin or bone marrow transport medium. All other liquid samples in bone marrow transport medium. Do not spindown or freeze samples before sending. Samples must arrive within 24 hours.
Turnaround time
Current service turnaround times: Urgent 1-7 calendar days; Non-urgent 5-10 calendar days; National targets: Urgent samples 95% reported within 14 days; Non-urgent 95% reported within 21 days
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
